INTERNATIONAL PATENT: THERINI BIO, INC. FILES APPLICATION FOR "DOSES OF ANTIBODIES WHICH BIND HUMAN FIBRIN YC OR FIBRINOGEN YC DOMAIN FOR NEURODEGENERATIVE DISEASES"

GENEVA, Nov. 12 -- THERINI BIO, INC. (2108 N Street, Suite 4963Sacramento, California 95816) filed a patent application (PCT/US2025/027460) for "DOSES OF ANTIBODIES WHICH BIND HUMAN FIBRIN YC OR FIBRINOGEN YC DOMAIN FOR NEURODEGENERATIVE DISEASES" on May 02, 2025. With publication no. WO/2025/231343, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KANTOR, Aaron Barth (c/o Therini Bio, Inc.2108 N Street, Suite 4963Sacramento, California 95816), STAVENHAGEN, Jeffrey (c/o Therini Bio, Inc.2108 N Street, Suite 4963Sacramento,...